Unlikely to cause harm — often a labeling or packaging issue.
Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.
| Distributed by / for | Actavis South Atlantic LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217; |
| NDC | 67767-142-30 |
| Full product label | buPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217; NDC 67767-142-30. |
| Recalling firm | Actavis South Atlantic LLC |
| Distribution | Nationwide |
| Quantity | 555,672 bottles |
| Recall initiated | 2013-03-22 |
| Report date | 2013-04-24 |
| Recall completed | 2014-05-09 |
| Recall number | D-248-2013 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Sunrise FL United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗